Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Skorniakov, Golubev, Kildyusheva, I. Motus (Ekaterinburg, Russian Federation). Management of drug resistant pulmonary TB. New problems and perspectives. Eur Respir J 2009; 34: Suppl. 53, 4452

Member's Comments

No comment yet.

Related content which might interest you: New perspectives in MDR-TB management Source: International Congress 2016 – China Session II Year: 2016 Basics of pulmonary and extrapulmonary TB epidemiology - drug resistance in Europe Source: Annual Congress 2003 - PG22 - Tuberculosis epidemiology and control Year: 2003 Fate or missed opportunities - challenges in diagnosing paediatric drug resistant tuberculosis in Germany Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 New guidelines to manage MDR-TB Source: School Course 13 Year: 2013 Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Current status of fluoroquinolone use for treatment of tuberculosis in Korea Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Non-pharmacological factors for the emergence of drug resistance in patients of pulmonary tuberculosis: An Indian overview Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 New and repurposed TB drugs use in children and adolescents with M/XDR-TB Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now? Year: 2017 New method of treatment of MDR destructive pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 527s Year: 2003 Social determinants of drug-susceptible and drug resistant tuberculosis Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges Source: Eur Respir J 2016; 48: 938-943 Year: 2016 New era of artificial pneumothorax in the management of multidrug resistant (MDR) pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 556s Year: 2003 Is there a need for prolonged follow up in mono-drug resistant TB? Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015 The global response to rifampicin-resistant tuberculosis: Current situation and recent trends Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Surgical complications of destructive pulmonary tuberculosis and ways of their correction Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with BA Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 New experiences from global use of new tools in TB management and control Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management Year: 2013 Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Source: Eur Respir J 2013; 42: 1449-1453 Year: 2013